SYSMEX CORPORATION (6869) Stock Price

Sysmex develops, manufactures, sells, services, and imports/exports specimen testing equipment and reagents primarily for the medical field. Specifically, the company provides equipment and reagents used in specimen testing such as blood tests and urinalysis, supporting diagnostic capabilities at medical institutions.

In addition to specimen testing equipment and reagents, Sysmex also provides related software, equipment maintenance, and academic support services. Through these offerings, the company proposes comprehensive solutions to address the diverse challenges faced by medical institutions.

Sysmex's business is organized into regional segments: Headquarters, Americas, EMEA, China, and AP. The Headquarters segment handles product development, manufacturing, and sales in Japan, while the other regional segments are responsible for manufacturing and sales in their respective areas.

These segments align with the segment information presented in Sysmex's consolidated financial statements. The classification of reporting segments has been revised in recent fiscal years, with details provided in the notes to the consolidated financial statements.

Sysmex has adopted "Sysmex Way" as its growth strategy, aiming for global trust and advancement. Beginning in April 2023, the company launched a new medium-term management plan focused on sustainable growth and strengthening its operational foundation. In particular, the company expects increased sales and profits through expanded product offerings and reinforced sales capabilities.

The company targets consolidated net sales of 560,000 million yen and operating profit of 112,000 million yen by the fiscal year ending March 2026. As digitalization in healthcare and the importance of self-medication grow, Sysmex has formulated a new long-term management strategy called "2033 (VA33)," which strengthens focus on advanced medical care and emerging market expansion.

Sysmex will enhance competitiveness in immunoassay and hematology fields while securing growth opportunities in emerging markets. The company is also expanding its business scope by adding medical robotics and regenerative cell therapy operations. Through these initiatives, Sysmex aims to achieve discontinuous growth.

Additionally, Sysmex pursues productivity improvements across the organization and creation of new solutions through digital transformation (DX). The company is committed to realizing sustainable management practices through environmental consideration and the development of an attractive workplace.